A Crosstalk Between Dual-Specific Phosphatases and Dual-Specific Protein Kinases Can Be A Potential Therapeutic Target for Anti-cancer Therapy

Author(s):  
Basak Celtikci
Author(s):  
Xinjie Liang ◽  
Xuefei Bao ◽  
Guoliang Chen

: SET protein is a multi-functional oncoprotein that is ubiquitously expressed in most tumor cells. Dysregulation of SET has been associated with many types of cancer. Due to ever-accumulating evidence of its strong correlation with both poor prognosis and drug resistance, the targeting of SET is starting to be explored. SET is currently regarded as a potential target for cancer therapy, and several inhibitors are being developed for clinical trials. In this review, the physiological and pathological functions of SET, as well as its antagonists, will be discussed along with the prospects and challenges involved with translating SET inhibitors into bona fide therapeutic options.


2019 ◽  
Vol 146 (1) ◽  
pp. 10-17 ◽  
Author(s):  
Valentina Sica ◽  
José Manuel Bravo‐San Pedro ◽  
Gautier Stoll ◽  
Guido Kroemer

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Min Lin ◽  
Zhi-wei Wang ◽  
Xueqiong Zhu

2018 ◽  
Vol 14 (2) ◽  
pp. 58-69 ◽  
Author(s):  
Waleed Alabdulmon ◽  
Homaidan T. Alhomaidan ◽  
Zafar Rasheed ◽  
Inamul Hasan Madar ◽  
Noura Alasmael ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document